NCT04443972 is a NA clinical trial of PD VitalOs cement® in Furcation Defects, sponsored by Hams Hamed Abdelrahman.

Who is sponsoring NCT04443972?

NCT04443972 is sponsored by Hams Hamed Abdelrahman.

What drugs are being tested in NCT04443972?

Interventions in NCT04443972: PD VitalOs cement®, Hydroxyapatite bone graft, biodegardable collagen membrane.

What condition does NCT04443972 study?

NCT04443972 studies Furcation Defects.

Is NCT04443972 still recruiting?

NCT04443972 is currently completed. Last updated 23 June 2020.

Last reviewed 2020-06-23 · How we verify

NCT04443972

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Injectable Beta-tricalcium Phosphate Clinically in Treatment of Grade II Furcation Involvement

Completed NA Last updated 23 June 2020

What this trial tests

NA trial testing PD VitalOs cement® in Furcation Defects in 14 participants. Completed in 4 February 2020.

Timeline

12 April 2018

Primary endpoint
10 July 2019

4 February 2020

Quick facts

Lead sponsor	Hams Hamed Abdelrahman
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	14
Start date	12 April 2018
Primary completion	10 July 2019
Estimated completion	4 February 2020
Sites	1 location across Egypt

Drugs / interventions tested

PD VitalOs cement®
Hydroxyapatite bone graft
biodegardable collagen membrane

Conditions studied

Furcation Defects — all drugs for Furcation Defects →

Sponsor

Hams Hamed Abdelrahman — full company profile →

Who can join

Adults 30 to 50, any sex, with Furcation Defects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to evaluate clinically and radiographically the use of PD VitalOs cement® bone graft in the treatment of class II furcation defects comparing with Hydroxyapatite bone graft and biodegradable collagen membrane in the treatment of class II furcation defects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Furcation Defects

Currently open trials in the same condition.

NCT06270303 — Use of a Bone Substitute Material in the Surgical Therapy of Furcation Defects · NA · recruiting

Other Hams Hamed Abdelrahman trials

Trials by the same sponsor.

NCT07044882 — Hydrodynamic Piezoelectric Technique in Internal Sinus Lift · NA · not yet recruiting
NCT07082634 — Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone · NA · not yet recruiting
NCT07044895 — Diode Laser Photocoagulation With Immediate Implant Placement · NA · not yet recruiting
NCT06759311 — Two Different Minimal Invasive Techniques in Caries Removal of Primary Teeth · NA · active not recruiting
NCT07103564 — The Effect of Local Melatonin Application Around Immediately Placed Implants in the Maxillary Premolar · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04443972 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hams Hamed Abdelrahman
Last refreshed: 23 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04443972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing